Wed 21 Oct 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Scientific Name | Trade Name | Updated Section | Month |
|---|---|---|---|
| Methotrexate | Jylamvo | 4.4 Special warnings and precautions for use , 4.5. Interactions with other medicinal products | Aug,2023 |
| Covid-19 Vaccine (Ad26.Cov2-S [Recombinant]) | Covid-19 Vaccine Janssen | 4.4 Special Warnings and Special Precautions for Use | Aug,2023 |
| Morphine Sulfate | Oramorph | 4.4 Special Warnings and Special Precautions for Use , 4.5. Interactions with other medicinal products , 4.8 Undesirable effects | Aug,2023 |
| Bupropion Hydrochloride; Naltrexone Hydrochloride | Wellbutrin | 4.8 Undesirable effects | Aug, 2024 |
| Teplizumab | Tzield | 4.8 Undesirable effects | Aug ,2026 |
| Vemurafenib | Zelboraf | 4.8 Undesirable effects | Aug ,2026 |
| Denosumab | Xgeva | 4.8 Undesirable effects | Aug ,2026 |
| Lixisenatide, insulin glargine | Soliqua | 4.4 Special warnings and precautions for use | Aug ,2026 |
| Teduglutide | Revestive | 4.8 Undesirable effects | Aug ,2026 |
| Sertraline Hydrochloride | Lustral | 4.8 Undesirable effects | April, 2026 |
Last update date: 04/10/2026 at 10:24 AM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.